This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Novo Nordisk is eyeing a cardiometabolic drug market future that is not purely dominated by incretins, after signing a $812m partnership with Deep Apple Therapeutics to access novel compounds for obesity and other diseases. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.
Ro5’s AI Chemistry Platform also uses advanced machine learning models and cheminformatics tools for quick compound discovery and design from hit identification to lead optimisation. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.
It recently initiated two more Phase III trials of its candidate CagriSema, as well as inking an $812m partnership with Deep Apple Therapeutics to access novel compounds, not GLP-1RAs, for obesity and other diseases. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.
Tariffs and trade disputes are further compounding this challenge, affecting the cost structure of pharma businesses. Can pharma tariffs “Make America Manufacture Again”? The complexity of customs regulations also means lead times for shipping protract, which can have a negative impact on clinical trials and product availability.
GMP/GLP and PPE training are applied to all employees, contractors and casual staff working in a GMP environment, including manufacturing, packaging, labelling, distribution, QA, QC, development, validation, engineering, IT staff and anyone whose activities could affect product quality. General Operating Procedures e. </p>
The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) is poised to grow at a compound annual growth rate of 5.3% Can pharma tariffs “Make America Manufacture Again”? Credit: Vitalii Vodolazskyi via Shutterstock. billion in 2024 to $10.3
CSPC will use its AI-powered drug discovery platform, which uses the technology to analyse the binding patterns of target proteins with existing compound molecules. Can pharma tariffs “Make America Manufacture Again”? The AI models work out targeted optimisation, advancing small molecules with the best developability.
During pharmacy school, I developed a keen interest in unconventional therapies, particularly compounding. While Western medicine was heavily process-oriented and protocol-driven, I was drawn to the innovative and sometimes unorthodox approaches that compounding offered. George Health & Wellness Magazine.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content